Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

KYMRKYMR
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in KYMERA THERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 1.2M shares of KYMR (KYMERA THERAPEUTICS INC), worth $136.2M as of 2026-Q2. The position was increased (+33.6% shares). KYMR represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$136.2M

Current Shares

1.2M

Total Value Change

+$118.7M

Total Shares Change

+753,389

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.2M
+33.6%
$136.2M0.0%$114.67
39
2026-Q1
Increased
888,409
+20.0%
$74M0.0%$86.35
35
2025-Q4
Increased
740,306
+4.1%
$57.6M0.0%$78.12
31
2025-Q3
Increased
711,444
+155.2%
$40.3M0.0%$58.50
47
2025-Q2
Decreased
278,736
-19.0%
$12.2M0.0%$44.12
0
2025-Q1
Decreased
344,237
-20.7%
$9.4M0.0%$29.62
0
2024-Q4
New
433,944
-
$17.5M0.0%$39.32
39

Other major holders of KYMR: FMR LLC, BAKER BROS. ADVISORS LP, Avoro Capital Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used